Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways

Peroxisome proliferator activated receptor γ (PPARγ) has been closely involved in the process of cardiovascular diseases. This study was to investigate whether pioglitazone (PIO), a PPARγ agonist, could protect against pressure overload-induced cardiac hypertrophy. Mice were orally given PIO (2.5 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wen-Ying, Ma, Zhen-Guo, Xu, Si-Chi, Zhang, Ning, Tang, Qi-Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826695/
https://www.ncbi.nlm.nih.gov/pubmed/27110236
http://dx.doi.org/10.1155/2016/9174190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826695/
https://www.ncbi.nlm.nih.gov/pubmed/27110236
http://dx.doi.org/10.1155/2016/9174190

Ejemplares similares